E3 SUMO-protein ligase PIAS2|Androgen receptor-interacting protein 3 (ARIP3)|DAB2-interacting protein (DIP)|E3 SUMO-protein transferase PIAS2|Msx-interacting zinc finger protein (Miz1)|PIAS-NY protein|Protein inhibitor of activated STAT x|Protein inhibitor of activated STAT2|PIAS2|PIASX antibody
货号:
FNab06429
反应性:
Human, Mouse, Rat
宿主:
Rabbit
验证实验:
ELISA, WB
克隆性:
polyclonal
亚型:
IgG
规格
价格
100μg
RMB ¥1900
50μg
RMB ¥1140
货期:
三个工作日+顺丰快递时长
产品介绍
实验结果
实验条件
常见问题
产品名称
PIAS2 antibody
货号
FNab06429
规格
100μg
状态
liquid
纯化方法
Immunogen affinity purified
纯度
≥95% as determined by SDS-PAGE
克隆性
polyclonal
亚型
IgG
存储
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
免疫原信息
免疫原
protein inhibitor of activated STAT, 2
别称
E3 SUMO-protein ligase PIAS2|Androgen receptor-interacting protein 3 (ARIP3)|DAB2-interacting protein (DIP)|E3 SUMO-protein transferase PIAS2|Msx-interacting zinc finger protein (Miz1)|PIAS-NY protein|Protein inhibitor of activated STAT x|Protein inhibitor of activated STAT2|PIAS2|PIASX antibody
HeLa cells were subjected to SDS PAGE followed by western blot with FNab06429(PIAS2 antibody) at dilution of 1:1500
背景介绍
Functions as an E3-type small ubiquitin-like modifier(SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulator in various cellular pathways, including the STAT pathway, the p53 pathway and the steroid hormone signaling pathway. The effects of this transcriptional coregulation, transactivation or silencing may vary depending upon the biological context and the PIAS2 isoform studied. However, it seems to be mostly involved in gene silencing. Binds to sumoylated ELK1 and enhances its transcriptional activity by preventing recruitment of HDAC2 by ELK1, thus reversing SUMO-mediated repression of ELK1 transactivation activity. Isoform PIAS2-beta, but not isoform PIAS2-alpha, promotes MDM2 sumoylation. Isoform PIAS2-alpha promotes PARK7 sumoylation. Isoform PIAS2-beta promotes NCOA2 sumoylation more efficiently than isoform PIAS2-alpha. Isoform PIAS2-alpha sumoylates PML at'Lys-65' and 'Lys-160'.